查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1338919

毛裡爾病市場、份額、市場規模、趨勢、行業分析報告：按治療、按應用、按最終用戶、按地區、按細分市場預測，2023-2032 年

Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- User; By Region; Segment Forecast, 2023-2032
出版日期: | 出版商: Polaris Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球毛病市場規模預計將達到7,412萬美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

隨著新的醫療趨勢的出現，Darrier 病預計將變得更加普遍。 將有更多的皮膚病治療方法來解決這種疾病的副作用，研究人員可能會獲得大量的財務支持來創造新的治療方法。 Darier 病（毛囊角化症）是一種罕見的遺傳性皮膚病，由 ATP2A2 基因突變引起。 此疾病的特徵是疣狀丘疹或斑塊，通常出現在頭皮、前額、胸部、背部和身體其他部位。

由於這種疾病的罕見性，達裡爾病的市場極小。 然而，包括 Castle Creek Pharmaceuticals 和 Hoss Therapeutics 在內的某些公司專注於開發罕見皮膚病的治療方法。 事實上，一些用於治療達裡爾病的藥物，如類維生素A和鈣調神經磷酸□抑制劑，也用於治療其他皮膚病，這可能有助於擴大這些藥物的市場。

不過，由於罕見疾病藥物的患者數量較少且開發成本較高，投資該領域的公司數量可能會受到限制。 COVID-19 的爆發對醫療保健產業產生了重大影響，許多醫療保健提供者和設施致力於治療 COVID-19 患者。 這導致了其他疾病的診斷和治療的延誤，包括達裡爾病等罕見疾病。 此外，疫情可能會擾亂臨床試驗和藥物開發計劃，影響達裡爾病新療法的可用性。 由於安全問題和患者進入醫療機構的機會有限，許多臨床試驗已被推遲或停止。

Drier 疾病市場報告亮點

預計在預測期內，外科手術將主導該行業的細分市場。 外科手術在減少疼痛和不適的同時改善結果的能力是行業擴張的主要驅動力。

外用類維生素A預計將在明年佔據較高的市場份額。 作為市場驅動因素，這些藥物治療症狀的有效性預計將在未來幾年內成長。

2022年皮膚科醫師佔佔比最大。 他們開處方、為患者提供支持，並在這種疾病的治療中發揮關鍵作用，使他們成為影響市場的主要力量。

預計北美的需求在預測期內將大幅成長。 由於醫療服務選擇範圍擴大和醫療成本上升等多種因素，預計未來幾年市場的主要驅動力將成長。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球乳牛病市場洞察

  • Darrier 疾病市場 - 最終用戶快照
  • Drier病市場動態
    • 推動者和機會
      • 對再生能源的需求不斷增加
      • 電力消耗需求增加
    • 抑制因素和挑戰
      • 初始成本高
  • PESTEL 分析
  • Darier 疾病市場的最終用戶趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第五章全球乳牛病市場（依治療）

  • 主要發現
  • 簡介
  • 醫學
  • 手術
  • 其他

第 6 章全球乳牛病市場，依應用劃分

  • 主要發現
  • 簡介
  • 外用維A酸
  • 口服維A酸
  • 其他

第 7 章最終使用者的全球乳牛病市場

  • 主要發現
  • 簡介
  • 皮膚科醫生
  • 居家護理
  • 醫院
  • 專科診所

第 8 章全球乳牛病市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年按地區劃分的Darrier 疾病市場評估
  • Darrier 疾病市場 - 北美
    • 北美：乳牛病市場，依治療方法，2019-2032 年
    • 北美：達裡爾疾病市場，按最終用戶劃分，2019-2032 年
    • 北美：乳牛疾病市場，依應用劃分，2019-2032 年
    • Darrier 疾病市場 - 美國
    • Drier 疾病市場 - 加拿大
  • Drier 疾病市場 - 歐洲
    • 歐洲：2019-2032 年乳牛病市場（依治療方法）
    • 歐洲：達裡爾疾病市場，以最終用戶劃分，2019-2032 年
    • 歐洲：乳牛疾病市場，依應用劃分，2019-2032 年
    • Drier 疾病市場 - 英國
    • Drier 疾病市場 - 法國
    • Drier 疾病市場 - 德國
    • Darrier 疾病市場 - 義大利
    • Darrier 疾病市場 - 西班牙
    • Drier 疾病市場 - 荷蘭
    • Drier 疾病市場 - 俄羅斯
  • Darrier 疾病市場 - 亞太地區
    • 亞太地區：乳牛病市場（依治療方法），2019-2032 年
    • 亞太地區：毛病市場，依最終使用者劃分，2019-2032 年
    • 亞太地區：乳牛疾病市場，依應用劃分，2019-2032 年
    • Darrier 疾病市場 - 中國
    • Drier 疾病市場 - 印度
    • Drier 疾病市場 - 馬來西亞
    • Darrier 疾病市場 - 日本
    • Darrier 疾病市場 - 印度尼西亞
    • Darrier 疾病市場 - 韓國
  • Darrier 疾病市場 - 中東和非洲
    • 中東和非洲：2019-2032 年毛裡爾病市場（依治療方法）
    • 中東和非洲：2019-2032 年達裡爾疾病市場（按最終用戶劃分）
    • 中東和非洲：毛病市場，按應用劃分，2019-2032 年
    • Drier 疾病市場 - 沙烏地阿拉伯
    • Darrier 疾病市場 - 阿拉伯聯合大公國
    • Drier 疾病市場 - 以色列
    • Drier 疾病市場 - 南非
  • Darrier 疾病市場 - 拉丁美洲
    • 拉丁美洲：水牛病市場（依治療方法），2019-2032 年
    • 拉丁美洲：達裡爾疾病市場，按最終用戶劃分，2019-2032 年
    • 拉丁美洲：乳牛病市場，按應用劃分，2019-2032 年
    • Drier 疾病市場 - 墨西哥
    • Drier 疾病市場 - 巴西
    • Drier 疾病市場 - 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • AbbVie
  • Amneal Pharmaceuticals
  • Bausch Health Companies
  • BridgeBio Pharma
  • Galderma
  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Johnson and Johnson
  • Laminar Pharma
  • Mayne Pharma
  • Merck
  • Novartis
  • Pfizer
  • Sawai Pharmaceutical
  • Sigmapharm Laboratories
  • Sun Pharmaceutical
  • Teva Pharmaceutical
  • Tolmar Pharmaceuticals
  • Validus Pharmaceuticals
  • Viatris
Product Code: PM3363

The global darier disease market size is expected to reach USD 74.12 million by 2032, according to a new study by Polaris Market Research. The report "Darier Disease Market Share, Size, Trends, Industry Analysis Report, By Treatment (Medication, Surgery, and Others); By Application; By End- Use; By Region; Segment Forecast, 2023-2032" gives a detailed insight into the current market dynamics and provides analysis on future market growth.

Darier disease is anticipated to spread as new healthcare trends emerge. More dermatological treatments will be available to address the condition's side effects, and researchers will receive sizeable financial support to create novel remedies. Darier disease, or keratosis follicularis, is a rare genetic skin disorder caused by mutations in the ATP2A2 gene. The disease is characterized by wart-like papules and plaques that typically appear on the scalp, forehead, chest, back, and other body areas.

Due to the condition's rarity, the market for Darier disease is quite small. Yet, certain businesses, including Castle Creek Pharmaceuticals & Hoth Therapeutics, are focused on creating treatments for uncommon skin conditions. The fact that some of the medications used to treat Darier disease, including retinoids and calcineurin inhibitors, are also used to treat other skin disorders may help to increase the market for these medications.

However, the small patient population and the high cost of developing rare disease therapies may limit the number of companies investing in this area. The COVID-19 pandemic has significantly impacted the healthcare industry, with many healthcare providers and facilities focused on treating patients with COVID-19. This has led to delays in diagnosing and treating other medical conditions, including rare diseases like Darier disease. Additionally, the pandemic has disrupted clinical trials and drug development programs, which may impact the availability of new treatments for Darier disease. Many trials have been delayed or suspended due to safety concerns and restrictions on patient access to healthcare facilities.

Darier Disease Market Report Highlights

Surgery is expected to dominate the industry's market sector during forecast period. The ability of the surgical industry to reduce pain and discomfort while improving results is the major factor driving its expansion.

Topical Retinoid will account for a higher share of the market in the upcoming year. Due to the effectiveness of these medications in treating the condition's symptoms, the primary driver driving the market is predicted to grow over the next several years.

Dermatologist accounted for the largest share in 2022. They are the primary force influencing the market because they are in charge of prescribing, offering patient support, and playing a crucial part in the care of this ailment.

The demand in North America is expected to witness significant growth during forecast period. The primary driver of the market is anticipated to rise in the upcoming years as a result of a number of factors, including the expansion of healthcare service options and rising healthcare costs.

Polaris Market Research has segmented the Darier Disease Market report based on treatment, application, end- user and region:

Darier Disease, Treatment Outlook (Revenue - USD Million, 2019 - 2032)

  • Medical
  • Surgery
  • Others

Darier Disease, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Topical Retinoids
  • Oral Retinoids
  • Others

Darier Disease, End- User Outlook (Revenue - USD Million, 2019 - 2032)

  • Dermatologist
  • Homecare
  • Hospitals
  • Specialty Clinics

Darier Disease, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Darier Disease Market Insights

  • 4.1. Darier Disease Market - End- User Snapshot
  • 4.2. Darier Disease Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in demand for renewable sources of energy
      • 4.2.1.2. Rise in demand for electricity consumption
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High initial costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Darier Disease Market End- User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Darier Disease Market, by Treatment

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • 5.3. Medical
    • 5.3.1. Global Darier Disease Market, by Medical, by Region, 2019-2032 (USD Million)
  • 5.4. Surgery
    • 5.4.1. Global Darier Disease Market, by Surgery, by Region, 2019-2032 (USD Million)
  • 5.5. Others
    • 5.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Darier Disease Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 6.3. Topical Retinoids
    • 6.3.1. Global Darier Disease Market, by Topical Retinoids, by Region, 2019-2032 (USD Million)
  • 6.4. Oral Retinoids
    • 6.4.1. Global Darier Disease Market, by Oral Retinoids, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Darier Disease Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Darier Disease Market, by End- User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • 7.3. Dermatologist
    • 7.3.1. Global Darier Disease Market, by Dermatologist, By Region, 2019-2032 (USD Million)
  • 7.4. Homecare
    • 7.4.1. Global Darier Disease Market, by Homecare, By Region, 2019-2032 (USD Million)
  • 7.5. Hospitals
    • 7.5.1. Global Darier Disease Market, by Hospitals, By Region, 2019-2032 (USD Million)
  • 7.6. Specialty Clinics
    • 7.6.1. Global Darier Disease Market, by Specialty Clinics, By Region, 2019-2032 (USD Million)

8. Global Darier Disease Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Darier Disease Market - North America
    • 8.3.1. North America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.2. North America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.3.3. North America: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Darier Disease Market - U.S.
      • 8.3.4.1. U.S.: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Darier Disease Market - Canada
      • 8.3.5.1. Canada: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.4. Darier Disease Market - Europe
    • 8.4.1. Europe: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Darier Disease Market - UK
      • 8.4.4.1. UK: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Darier Disease Market - France
      • 8.4.5.1. France: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Darier Disease Market - Germany
      • 8.4.6.1. Germany: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Darier Disease Market - Italy
      • 8.4.7.1. Italy: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Darier Disease Market - Spain
      • 8.4.8.1. Spain: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Darier Disease Market - Netherlands
      • 8.4.9.1. Netherlands: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Darier Disease Market - Russia
      • 8.4.10.1. Russia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.5. Darier Disease Market - Asia Pacific
    • 8.5.1. Asia Pacific: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Darier Disease Market - China
      • 8.5.4.1. China: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Darier Disease Market - India
      • 8.5.5.1. India: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Darier Disease Market - Malaysia
      • 8.5.6.1. Malaysia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Darier Disease Market - Japan
      • 8.5.7.1. Japan: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Darier Disease Market - Indonesia
      • 8.5.8.1. Indonesia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Darier Disease Market - South Korea
      • 8.5.9.1. South Korea: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.6. Darier Disease Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Darier Disease Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Darier Disease Market - UAE
      • 8.6.5.1. UAE: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Darier Disease Market - Israel
      • 8.6.6.1. Israel: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Darier Disease Market - South Africa
      • 8.6.7.1. South Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • 8.7. Darier Disease Market - Latin America
    • 8.7.1. Latin America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Darier Disease Market - Mexico
      • 8.7.4.1. Mexico: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Darier Disease Market - Brazil
      • 8.7.5.1. Brazil: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Darier Disease Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Darier Disease Market - Argentina
      • 8.7.6.1. Argentina: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Darier Disease Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Amneal Pharmaceuticals
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bausch Health Companies
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BridgeBio Pharma
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Galderma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. GlaxoSmithKline
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Glenmark Pharmaceuticals
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson and Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Laminar Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Mayne Pharma
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Merck
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Novartis
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Pfizer
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Sawai Pharmaceutical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Sigmapharm Laboratories
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Sun Pharmaceutical
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Teva Pharmaceutical
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
  • 10.18. Tolmar Pharmaceuticals
    • 10.18.1. Company Overview
    • 10.18.2. Financial Performance
    • 10.18.3. Product Benchmarking
    • 10.18.4. Recent Development
  • 10.19. Validus Pharmaceuticals
    • 10.19.1. Company Overview
    • 10.19.2. Financial Performance
    • 10.19.3. Product Benchmarking
    • 10.19.4. Recent Development
  • 10.20. Viatris
    • 10.20.1. Company Overview
    • 10.20.2. Financial Performance
    • 10.20.3. Product Benchmarking
    • 10.20.4. Recent Development

List of Tables

  • Table 1 Global Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 2 Global Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 4 Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 6 North America: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 8 U.S.: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 9 U.S.: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 11 Canada: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 12 Canada: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 14 Europe: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 15 Europe: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 17 UK: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 18 UK: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 20 France: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 21 France: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 23 Germany: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 24 Germany: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 26 Italy: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 27 Italy: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 29 Spain: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 30 Spain: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 33 Netherlands: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 35 Russia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 36 Russia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 41 China: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 42 China: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 44 India: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 45 India: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 48 Malaysia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 50 Japan: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 51 Japan: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 54 Indonesia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 56 South Korea: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 57 South Korea: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 65 UAE: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 66 UAE: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 68 Israel: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 69 Israel: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 71 South Africa: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 72 South Africa: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 74 Latin America: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 75 Latin America: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 77 Mexico: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 78 Mexico: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 80 Brazil: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 81 Brazil: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Darier Disease Market, by End- User, 2019-2032 (USD Million)
  • Table 83 Argentina: Darier Disease Market, by Treatment, 2019-2032 (USD Million)
  • Table 84 Argentina: Darier Disease Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Darier Disease Market, by End- User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Darier Disease Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Darier Disease Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Treatment
  • Figure 9. Global Darier Disease Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 10. Market by End- User
  • Figure 11. Global Darier Disease Market, by End- User, 2022 & 2032 (USD Million)
  • Figure 12. Darier Disease Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Darier Disease Market